<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02117999</url>
  </required_header>
  <id_info>
    <org_study_id>SEA27</org_study_id>
    <secondary_id>PON01_00110</secondary_id>
    <nct_id>NCT02117999</nct_id>
  </id_info>
  <brief_title>Transepithelial Corneal Cross-linking Using Iontophoresis</brief_title>
  <acronym>T-iontoCL</acronym>
  <official_title>Randomized Clinical Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis and Standard Corneal Cross-linking for the Treatment of Keratoconus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione G.B. Bietti, IRCCS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CNR Institute for chemical and physical processes (IPCF), Messina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fondazione G.B. Bietti, IRCCS</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the present Randomized Clinical Trial (RCT) is to compare the efficacy and
      safety of transepithelial corneal cross-linking using iontophoresis (T-ionto CL) to treat
      progressive keratoconus in comparison with standard cross-linking (standard CL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Keratoconus is a progressive corneal ectatic disease causing visual impairment by inducing
      irregular astigmatism and corneal opacity. This disorder typically begins during the second
      decade of life and, in severe forms, may need a corneal transplantation. Corneal
      cross-linking with riboflavin and UV-A is a procedure intended to halt keratoconus
      progression. It generates additional chemical bonds between stromal proteins in order to
      stiffen the corneal tissue. Standard CL includes epithelial removal and stroma soaking with
      dextran-enriched 0.1% riboflavin solution for 30 minutes before being exposed to
      ultraviolet-A radiation using a 3mW/cm2 lamp for 30 minutes.

      Epithelial debridement exposes the cornea to a risk of side effects, such as pain for the
      first two post-operative days, temporary loss of visual acuity during the first three months,
      and serious complications, such as infection and stromal opacity due to corneal scarring.

      Iontophoresis is a non invasive technique in which a weak electric current is used to enhance
      the penetration of hypotonic 0.1% riboflavin-5-phosphate solution into the corneal stroma
      through the intact epithelium. After iontophoresis, the corneal tissue is irradiated using a
      10 mW/cm2 for 9 minutes (T-ionto CL). From previous experimental work (Lombardo M. et al.
      JCRS 2014 and JCRS 2015), the investigators provided evidence that T-ionto CL increases the
      stiffness of human corneas with results almost comparable with standard CL. The new procedure
      holds the promise to be as effective as the standard procedure while minimizing all the
      related risks. It is object of the present clinical trial to randomize patients with
      progressive keratoconus to T-ionto CL and standard CL and compare efficacy and safety of
      treatments.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Consecutive patients were randomized, using block randomization model, in one of the arm</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>K-max</measure>
    <time_frame>Changes from baseline in Kmax at 12 months</time_frame>
    <description>Measuring maximum keratometry (K-max), measured in diopters (D), derived from computerized videokeratography.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corneal Endothelial Cell Density</measure>
    <time_frame>Changes from baseline in ECD at 12 months</time_frame>
    <description>Endothelial cell density (ECD) will be evaluated using specular microscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Optical Aberrations</measure>
    <time_frame>Changes from baseline at 12 months.</time_frame>
    <description>Optical aberrations of the eye will be measured using dynamic skyascopy. Corneal wavefront aberration will be measured using Placido disk topographer and Scheimpflug tomographer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>Changes from baseline at 12 months.</time_frame>
    <description>Visual acuity tested using ETDRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast Sensitivity</measure>
    <time_frame>Changes from baseline at 12 months.</time_frame>
    <description>Contrast sensitivity tested using Pelli-Robson chart</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central Retinal Thickness</measure>
    <time_frame>Changes from baseline at 12 months.</time_frame>
    <description>Central retinal thickness (1 mm ETDRS map) will be measured before and after CXL procedures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Progressive Keratoconus</condition>
  <arm_group>
    <arm_group_label>Cross-linking with iontophoresis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transepithelial cross-linking by using iontophoresis to administer riboflavin into the corneal stroma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard corneal cross-linking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard corneal cross-linking includes de-epithelialization and stromal soaking by applying drops of riboflavin</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cross-linking with iontophoresis</intervention_name>
    <description>The procedure involves a constant current source and two electrodes. The active electrode is a bath tube, which includes a stainless steel grid, placed into the cup at a minimal distance from the cornea. The reservoir is filled with dextran-free, hypotonic riboflavin-5-phosphate solution. The generator applies a constant current of 1mA for a preset period of 5 min. After the riboflavin administration by iontophoresis, the cornea is irradiated using a UVA lamp of 10mW/cm2 for 9 minutes.</description>
    <arm_group_label>Cross-linking with iontophoresis</arm_group_label>
    <other_name>Ricrolin+</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard corneal cross-linking</intervention_name>
    <description>In the standard CL, the epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated using a UVA lamp of 3mW/cm2 for 30 minutes.</description>
    <arm_group_label>Standard corneal cross-linking</arm_group_label>
    <other_name>Ricrolin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of progressive keratoconus

        Exclusion Criteria:

          -  Anterior corneal curvature steeper than 61 D;

          -  central corneal thickness &lt;400 um

          -  corneal scarring;

          -  descemetocele;

          -  history of herpetic keratitis;

          -  Concomitant eye diseases;

          -  Inflammatory eye diseases;

          -  Glaucoma;

          -  Cataract;

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>46 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Lombardo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fondazione G.B. Bietti, IRCCS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fondazione G.B. Bietti, IRCCS</name>
      <address>
        <city>Rome</city>
        <zip>00198</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <link>
    <url>http://www.fondazionebietti.it</url>
    <description>Inclusion and exclusion criteria to the present RCT are shown in the main website page</description>
  </link>
  <reference>
    <citation>Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998 Jan;66(1):97-103.</citation>
    <PMID>9533835</PMID>
  </reference>
  <reference>
    <citation>Hao J, Li SK, Liu CY, Kao WW. Electrically assisted delivery of macromolecules into the corneal epithelium. Exp Eye Res. 2009 Dec;89(6):934-41. doi: 10.1016/j.exer.2009.08.001. Epub 2009 Aug 12.</citation>
    <PMID>19682448</PMID>
  </reference>
  <reference>
    <citation>Eljarrat-Binstock E, Domb AJ. Iontophoresis: a non-invasive ocular drug delivery. J Control Release. 2006 Feb 21;110(3):479-89. Epub 2005 Dec 15. Review.</citation>
    <PMID>16343678</PMID>
  </reference>
  <reference>
    <citation>Bikbova G, Bikbov M. Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin. Acta Ophthalmol. 2014 Feb;92(1):e30-4. doi: 10.1111/aos.12235. Epub 2013 Jul 15.</citation>
    <PMID>23848196</PMID>
  </reference>
  <reference>
    <citation>Meek KM, Hayes S. Corneal cross-linking--a review. Ophthalmic Physiol Opt. 2013 Mar;33(2):78-93. doi: 10.1111/opo.12032. Review.</citation>
    <PMID>23406488</PMID>
  </reference>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 11, 2014</study_first_submitted>
  <study_first_submitted_qc>April 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 21, 2014</study_first_posted>
  <results_first_submitted>March 29, 2017</results_first_submitted>
  <results_first_submitted_qc>August 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 8, 2019</results_first_posted>
  <last_update_submitted>August 2, 2019</last_update_submitted>
  <last_update_submitted_qc>August 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione G.B. Bietti, IRCCS</investigator_affiliation>
    <investigator_full_name>Marco Lombardo</investigator_full_name>
    <investigator_title>Dr. Marco Lombardo</investigator_title>
  </responsible_party>
  <keyword>corneal cross-linking</keyword>
  <keyword>transepithelial corneal cross-linking</keyword>
  <keyword>iontophoresis</keyword>
  <keyword>progressive keratoconus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>still investigating this study population up to 3 years after treatment</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Eligible patients were randomized after enrolment, with allocation ratio of 2:1, into either the study or control group</recruitment_details>
      <pre_assignment_details>Block randomization strategy was used to randomize units with comparable baseline Kmax values in either group.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>T-ionto CL</title>
          <description>Eyes undergoing transepithelial corneal cross-linking with iontophoresis</description>
        </group>
        <group group_id="P2">
          <title>Standard CL</title>
          <description>Eyes undergoing standard corneal cross-linking</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Mean Kmax Change in Corneal Topography</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard CL</title>
          <description>Participants undergoing standard corneal cross-linking</description>
        </group>
        <group group_id="B2">
          <title>T-ionto CL</title>
          <description>Participants undergoing transepithelial corneal cross-linking with iontophoresis</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="30"/>
          </count_list>
        </analyzed>
        <analyzed>
          <units>eyes</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="22"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.4" spread="5.6"/>
                    <measurement group_id="B2" value="31" spread="6.6"/>
                    <measurement group_id="B3" value="30" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>eyes</units>
          <param>Count of Units</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>eyes</units>
          <param>Number</param>
          <units_analyzed>eyes</units_analyzed>
          <class_list>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>family history of keratoconus</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <units_analyzed>Participants</units_analyzed>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>K-max</title>
        <description>Measuring maximum keratometry (K-max), measured in diopters (D), derived from computerized videokeratography.</description>
        <time_frame>Changes from baseline in Kmax at 12 months</time_frame>
        <population>Analysis of changes from baseline in each group was made using the paired Student t-test. Treatment effects were assessed using repeated measures ANOVA between groups and time (3 days, 7 days, 1-, 3-, 6- and 12-months). The outcome measures over time were corrected for baseline values.</population>
        <group_list>
          <group group_id="O1">
            <title>Transepithelial Corneal Cross-linking Using Iontophoresis</title>
            <description>Transepithelial corneal cross-linking using iontophoresis
Transepithelial corneal cross-linking using iontophoresis: The procedure involves a constant current source and two electrodes. The active electrode is a bath tube, which includes a stainless steel grid, placed into the cup at a minimal distance from the cornea. The reservoir is filled with dextran-free, hypotonic riboflavin-5-phosphate solution. The generator applies a constant current of 1mA for a preset period of 5 min. After the riboflavin administration by iontophoresis, the cornea is irradiated using a UVA lamp of 10mW/cm2 for 9 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Standard Corneal Cross-linking</title>
            <description>Standard corneal cross-linking
Standard corneal cross-linking: In the standard CL, the epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated using a UVA lamp of 3mW/cm2 for 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>K-max</title>
          <description>Measuring maximum keratometry (K-max), measured in diopters (D), derived from computerized videokeratography.</description>
          <population>Analysis of changes from baseline in each group was made using the paired Student t-test. Treatment effects were assessed using repeated measures ANOVA between groups and time (3 days, 7 days, 1-, 3-, 6- and 12-months). The outcome measures over time were corrected for baseline values.</population>
          <units>Diopters (D)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.52" spread="1.30"/>
                    <measurement group_id="O2" value="-0.82" spread="1.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis of changes from baseline in each group was made using the paired Student t-test. Treatment effects were assessed using repeated measures ANOVA between groups and time (3 days, 7 days, 1-, 3-, 6- and 12-months). The outcome measures over time were corrected for baseline values. The relationship between the change in Kmax at 12 months and baseline parameters was assessed using Pearson’s correlation analysis for either group.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Sample size calculation was performed to detect a difference of 0.95 D between the average Kmax changes for the T-ionto CL and standard CL groups at 12 months, at a significance level of 5% and a power of 81%, assuming a standard deviation of 1.20 D.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Corneal Endothelial Cell Density</title>
        <description>Endothelial cell density (ECD) will be evaluated using specular microscopy</description>
        <time_frame>Changes from baseline in ECD at 12 months</time_frame>
        <population>Analysis of changes from baseline in each group was made using the paired Student t-test. Treatment effects were assessed using repeated measures ANOVA between groups and time (3 days, 7 days, 1-, 3-, 6- and 12-months). The outcome measures over time were corrected for baseline values.</population>
        <group_list>
          <group group_id="O1">
            <title>Transepithelial Corneal Cross-linking Using Iontophoresis</title>
            <description>Transepithelial corneal cross-linking using iontophoresis
Transepithelial corneal cross-linking using iontophoresis: The procedure involves a constant current source and two electrodes. The active electrode is a bath tube, which includes a stainless steel grid, placed into the cup at a minimal distance from the cornea. The reservoir is filled with dextran-free, hypotonic riboflavin-5-phosphate solution. The generator applies a constant current of 1mA for a preset period of 5 min. After the riboflavin administration by iontophoresis, the cornea is irradiated using a UVA lamp of 10mW/cm2 for 9 minutes.</description>
          </group>
          <group group_id="O2">
            <title>Standard Corneal Cross-linking</title>
            <description>Standard corneal cross-linking
Standard corneal cross-linking: In the standard CL, the epithelium is mechanically removed. Then, a solution of riboflavin is instilled each minute for 30 minutes. Corneas are irradiated using a UVA lamp of 3mW/cm2 for 30 minutes.</description>
          </group>
        </group_list>
        <measure>
          <title>Corneal Endothelial Cell Density</title>
          <description>Endothelial cell density (ECD) will be evaluated using specular microscopy</description>
          <population>Analysis of changes from baseline in each group was made using the paired Student t-test. Treatment effects were assessed using repeated measures ANOVA between groups and time (3 days, 7 days, 1-, 3-, 6- and 12-months). The outcome measures over time were corrected for baseline values.</population>
          <units>cells/mm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2675" spread="311"/>
                    <measurement group_id="O2" value="2658" spread="321"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis of changes from baseline in each group was made using the paired Student t-test. Treatment effects were assessed using repeated measures ANOVA between groups and time (3 days, 7 days, 1-, 3-, 6- and 12-months). The outcome measures over time were corrected for baseline values.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>sample size calculation was performed to detect a difference of 0.95 D between the average Kmax changes for the T-ionto CL and standard CL groups at 12 months, at a significance level of 5% and a power of 81%, assuming a standard deviation of 1.20 D. The sample size of the study was 34 cases (allocation ratio of 2:1)</non_inferiority_desc>
            <p_value>0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>35</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Optical Aberrations</title>
        <description>Optical aberrations of the eye will be measured using dynamic skyascopy. Corneal wavefront aberration will be measured using Placido disk topographer and Scheimpflug tomographer.</description>
        <time_frame>Changes from baseline at 12 months.</time_frame>
        <population>Corneal high-order aberrations</population>
        <group_list>
          <group group_id="O1">
            <title>T-ionto CL</title>
            <description>Participants undergoing transepithelial corneal cross-linking with iontophoresis</description>
          </group>
          <group group_id="O2">
            <title>Standard CL</title>
            <description>Participants undergoing standard corneal cross-linking</description>
          </group>
        </group_list>
        <measure>
          <title>Optical Aberrations</title>
          <description>Optical aberrations of the eye will be measured using dynamic skyascopy. Corneal wavefront aberration will be measured using Placido disk topographer and Scheimpflug tomographer.</description>
          <population>Corneal high-order aberrations</population>
          <units>micrometers</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.19" spread="0.99"/>
                    <measurement group_id="O2" value="2.21" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Acuity</title>
        <description>Visual acuity tested using ETDRS</description>
        <time_frame>Changes from baseline at 12 months.</time_frame>
        <population>Corrected distance visual acuity</population>
        <group_list>
          <group group_id="O1">
            <title>T-ionto CL</title>
            <description>Participants undergoing transepithelial corneal cross-linking with iontophoresis</description>
          </group>
          <group group_id="O2">
            <title>Standard CL</title>
            <description>Participants undergoing standard corneal cross-linking</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity</title>
          <description>Visual acuity tested using ETDRS</description>
          <population>Corrected distance visual acuity</population>
          <units>LogMAR</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.10"/>
                    <measurement group_id="O2" value="0.01" spread="0.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Contrast Sensitivity</title>
        <description>Contrast sensitivity tested using Pelli-Robson chart</description>
        <time_frame>Changes from baseline at 12 months.</time_frame>
        <population>Contrast-sensitivity function assessed by Pelli-Robson charts</population>
        <group_list>
          <group group_id="O1">
            <title>T-ionto CL</title>
            <description>Participants undergoing transepithelial corneal cross-linking with iontophoresis</description>
          </group>
          <group group_id="O2">
            <title>Standard CL</title>
            <description>Participants undergoing standard corneal cross-linking</description>
          </group>
        </group_list>
        <measure>
          <title>Contrast Sensitivity</title>
          <description>Contrast sensitivity tested using Pelli-Robson chart</description>
          <population>Contrast-sensitivity function assessed by Pelli-Robson charts</population>
          <units>log</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.62" spread="0.08"/>
                    <measurement group_id="O2" value="1.63" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Central Retinal Thickness</title>
        <description>Central retinal thickness (1 mm ETDRS map) will be measured before and after CXL procedures</description>
        <time_frame>Changes from baseline at 12 months.</time_frame>
        <population>1 mm central retinal thickness assessed by SD-OCT</population>
        <group_list>
          <group group_id="O1">
            <title>T-ionto CL</title>
            <description>Participants undergoing transepithelial corneal cross-linking with iontophoresis</description>
          </group>
          <group group_id="O2">
            <title>Standard CL</title>
            <description>Participants undergoing standard corneal cross-linking</description>
          </group>
        </group_list>
        <measure>
          <title>Central Retinal Thickness</title>
          <description>Central retinal thickness (1 mm ETDRS map) will be measured before and after CXL procedures</description>
          <population>1 mm central retinal thickness assessed by SD-OCT</population>
          <units>micrometers</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="275" spread="20"/>
                    <measurement group_id="O2" value="277" spread="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>no differences</desc>
      <group_list>
        <group group_id="E1">
          <title>Transepithelial Corneal Cross-linking Using Iontophoresis</title>
          <description>Participants undergoing transepithelial corneal cross-linking using iontophoresis</description>
        </group>
        <group group_id="E2">
          <title>Standard Corneal Cross-linking</title>
          <description>Participants undergoing standard corneal cross-linking</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Corneal sub-epithelial infiltrates</sub_title>
                <description>Corneal peripheral sub-epithelial infiltrates</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Principal Investigator (PI) is NOT employed by the organization sponsoring the study. There is NOT an agreement between the PI and the Sponsor that restricts the PI's rights to discuss or publish trial results after the trial is completed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Marco Lombardo</name_or_title>
      <organization>Studio Italiano di Oftalmologia</organization>
      <phone>+39 331 34 38 300</phone>
      <email>mlombardo@visioeng.it</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

